Carl Byrnes

Stock Analyst at Northland Capital Markets

(2.38)
# 2,629
Out of 5,044 analysts
25
Total ratings
52.94%
Success rate
10.9%
Average return

Stocks Rated by Carl Byrnes

SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $31.02
Upside: +77.30%
BrainsWay
Aug 14, 2025
Maintains: Outperform
Price Target: $15$19
Current: $17.01
Upside: +11.70%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28$31
Current: $28.04
Upside: +10.56%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $5.02
Upside: +149.00%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $2.12
Upside: +183.02%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.81
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40$25
Current: $19.24
Upside: +29.94%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $3.91
Upside: +6,038.11%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60$80
Current: $21.19
Upside: +277.54%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $6.73
Upside: +241.75%
Maintains: Market Perform
Price Target: $30$24
Current: $2.90
Upside: +727.59%
Initiates: Outperform
Price Target: $2,000
Current: $2.21
Upside: +90,397.74%
Initiates: Outperform
Price Target: n/a
Current: $1.18
Upside: -